ENDRA Life Sciences (NDRA) Net Income towards Common Stockholders (2016 - 2021)
Historic Net Income towards Common Stockholders for ENDRA Life Sciences (NDRA) over the last 6 years, with Q4 2021 value amounting to -$3.1 million.
- ENDRA Life Sciences' Net Income towards Common Stockholders fell 3793.68% to -$3.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$11.4 million, marking a year-over-year increase of 634.21%. This contributed to the annual value of -$11.5 million for FY2024, which is 1439.03% down from last year.
- ENDRA Life Sciences' Net Income towards Common Stockholders amounted to -$3.1 million in Q4 2021, which was down 3793.68% from -$2.7 million recorded in Q3 2021.
- Over the past 5 years, ENDRA Life Sciences' Net Income towards Common Stockholders peaked at -$741623.0 during Q1 2017, and registered a low of -$9.0 million during Q4 2019.
- Its 5-year average for Net Income towards Common Stockholders is -$2.8 million, with a median of -$2.7 million in 2019.
- In the last 5 years, ENDRA Life Sciences' Net Income towards Common Stockholders crashed by 28168.05% in 2019 and then surged by 7507.21% in 2020.
- ENDRA Life Sciences' Net Income towards Common Stockholders (Quarter) stood at -$2.3 million in 2017, then decreased by 3.09% to -$2.4 million in 2018, then tumbled by 281.68% to -$9.0 million in 2019, then soared by 75.07% to -$2.3 million in 2020, then crashed by 37.94% to -$3.1 million in 2021.
- Its Net Income towards Common Stockholders was -$3.1 million in Q4 2021, compared to -$2.7 million in Q3 2021 and -$3.2 million in Q2 2021.